Titan Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 47.22 | 36.55 | 39.87 |
| Operating Expense | 37.76 | 30.60 | 33.43 |
| Net Profit | 6.16 | 3.77 | 3.80 |
| Net Profit Margin | 13.05 | 10.31 | 9.53 |
| Earning Per Share | 7.46 | 4.56 | 4.60 |
| EBIDTA | 9.43 | 5.94 | 6.41 |
| Effective Tax Rate | 20.30 | 21.01 | 19.88 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 47.22 |
| Operating Expense | 37.76 |
| Net Profit | 6.16 |
| Net Profit Margin | 13.05 |
| Earning Per Share | 7.46 |
| EBIDTA | 9.43 |
| Effective Tax Rate | 20.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 156.45 | 164.07 | 144.00 |
| Operating Expenses Annual | 131.02 | 129.79 | 114.48 |
| Operating Profit Annual | 29.34 | 36.03 | 31.46 |
| Interest Annual | 0.80 | 1.17 | 0.75 |
| Depreciation | 3.69 | 2.84 | 2.12 |
| Net Profit Annual | 18.27 | 23.66 | 21.02 |
| Tax Annual | 6.10 | 7.87 | 7.09 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 156.45 |
| Operating Expenses Annual | 131.02 |
| Operating Profit Annual | 29.34 |
| Interest Annual | 0.80 |
| Depreciation | 3.69 |
| Net Profit Annual | 18.27 |
| Tax Annual | 6.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.84 | 4.86 | 6.81 |
| Cash Flow from Operations | 20.12 | 21.15 | 21.18 |
| Cash Flow from Investing | -9.87 | -20.30 | -20.73 |
| Cash Flow from Financing | -7.96 | -2.87 | -2.40 |
| Cash Flow at the End | 5.13 | 2.84 | 4.86 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 2.84 |
| Cash Flow from Operations | 20.12 |
| Cash Flow from Investing | -9.87 |
| Cash Flow from Financing | -7.96 |
| Cash Flow at the End | 5.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 18.75 | 21.96 | 21.85 |
| PBIT Margin (%) | 16.09 | 19.93 | 20.05 |
| PBT Margin (%) | -4.02 | 2.89 | -6.67 |
| Net PROFIT Margin (%) | 11.68 | 14.42 | 14.60 |
| Return On Networth / Equity (%) | 13.36 | 20.18 | 21.86 |
| Return On Networth /Employed (%) | 17.49 | 25.70 | 27.12 |
| Return On Assets (%) | 12.73 | 18.60 | 19.71 |
| Total Debt / Equity (X) | 0.04 | 0.07 | 0.09 |
| Asset Turnover Ratio (%) | 1.09 | 1.29 | 1.35 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 18.75 |
| PBIT Margin (%) | 16.09 |
| PBT Margin (%) | -4.02 |
| Net PROFIT Margin (%) | 11.68 |
| Return On Networth / Equity (%) | 13.36 |
| Return On Networth /Employed (%) | 17.49 |
| Return On Assets (%) | 12.73 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 1.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 57.28 | 52.03 | 35.89 |
| Total Current Assets Annual | 79.04 | 72.62 | 68.31 |
| Non Current Assets Annual | 87.40 | 79.40 | 62.39 |
| Total Shareholders Funds Annual | 145.13 | 128.44 | 106.09 |
| Total Assets Annual | 166.44 | 152.02 | 130.70 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 57.28 |
| Total Current Assets Annual | 79.04 |
| Non Current Assets Annual | 87.40 |
| Total Shareholders Funds Annual | 145.13 |
| Total Assets Annual | 166.44 |
EPS (INR)
Expected
8.31
Reported
8.30
Surprise
-0.12%
Mar 2025
EPS beaten by -0.12%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
